Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2/3 study of Breast-cancer-vaccine

Next Previous
Trial Profile

Phase 2/3 study of Breast-cancer-vaccine

Status: Planning
Phase of Trial: Phase II/III

Latest Information Update: 26 Dec 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 15 Dec 2025 According to Anixa Biosciences media release, the company has completed the transfer of the IND for its breast cancer vaccine from Cleveland Clinic. Anixa plans to advance the vaccine into a Phase 2 clinical trial and has assumed full sponsorship of the IND. Anixa plans to utilize multiple clinical sites, including Cleveland Clinic, for the Phase 2 and other clinical trials.
  • 11 Dec 2025 According to an Anixa Biosciences media release, final data from the phase 1 trial will inform the design of the planned phase 2 trial.
  • 05 Nov 2025 According to Anixa Biosciences media release, Anixa plans to advance the vaccine into a Phase 2 clinical trial and will assume full sponsorship of the IND. For this it has executed a data transfer agreement (DTA) with Cleveland Clinic, as a key step in the process of transferring the breast cancer vaccine clinical trial data and sponsorship to Anixa for future clinical development.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top